GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EUDA Health Holdings Ltd (NAS:EUDA) » Definitions » Cash Flow from Financing

EUDA Health Holdings (EUDA Health Holdings) Cash Flow from Financing : $1.54 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is EUDA Health Holdings Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2023, EUDA Health Holdings paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, EUDA Health Holdings spent $0.00 Mil on financial activities for the three months ended in Jun. 2023.


EUDA Health Holdings Cash Flow from Financing Historical Data

The historical data trend for EUDA Health Holdings's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EUDA Health Holdings Cash Flow from Financing Chart

EUDA Health Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
0.21 -0.17 2.49 2.35

EUDA Health Holdings Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 - 0.53 - -

EUDA Health Holdings Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

EUDA Health Holdings's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

EUDA Health Holdings's Cash from Financing for the quarter that ended in Jun. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EUDA Health Holdings  (NAS:EUDA) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

EUDA Health Holdings's issuance of stock for the three months ended in Jun. 2023 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

EUDA Health Holdings's repurchase of stock for the three months ended in Jun. 2023 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

EUDA Health Holdings's net issuance of debt for the three months ended in Jun. 2023 was $0.00 Mil. EUDA Health Holdings received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

EUDA Health Holdings's net issuance of preferred for the three months ended in Jun. 2023 was $0.00 Mil. EUDA Health Holdings paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

EUDA Health Holdings's cash flow for dividends for the three months ended in Jun. 2023 was $0.00 Mil. EUDA Health Holdings received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

EUDA Health Holdings's other financing for the three months ended in Jun. 2023 was $0.00 Mil. EUDA Health Holdings received $0.00 Mil on other financial activities.


EUDA Health Holdings Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of EUDA Health Holdings's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


EUDA Health Holdings (EUDA Health Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1 Pemimpin Drive No. 12-07, One Pemimpin, Singapore, SGP, 576151
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
Executives
Kongyew Wong director C/O 6 EU TONG SEN STREET, #08-13, THE CENTRAL U0 059817
Chen Wei Wen Kelvin director, officer: CHIEF EXECUTIVE OFFICER C/O 1 PEMIMPIN DRIVE #12-07,, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Alfred Lim director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Kim Hing Chan director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
David Francis Capes director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Daniel Tan officer: CHIEF TECHNOLOGY OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Steven John Sobak officer: CHIEF FINANCIAL OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Lim Thien Su Gerald director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Tan Meng Dong (james) director, 10 percent owner, officer: Chief Executive Officer UNIT 2003 KINGKEY 100, TOWER B, 5015 SHENNAN EAST ROAD, LUOHU DISTRICT, SHENZHEN/GUANGDONG F4 518000
Alexander K. Arrow director PO BOX 3094, REDWOOD CITY CA 94064
Kwong Yeow Liew director RM 2313-2315, BLOCK B, ZHONGSHEN GARDEN, SHENZHEN F4 518101
Yap Guan Hong William director, officer: Chief Financial Officer 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
Ajay Rajpal director 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
8i Holdings 2 Pte Ltd 10 percent owner C/O 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817